Chapter/Section Purchase

1 Study Coverage
1.1 Microbial Alternative Protein Product Introduction
1.2 Market by Type
1.2.1 Global Microbial Alternative Protein Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Emerging Alternative Protein
1.2.3 Adolescent Alternative Protein
1.2.4 Matured Alternative Protein
1.3 Market by Application
1.3.1 Global Microbial Alternative Protein Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Food
1.3.3 Feed
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Microbial Alternative Protein Sales Estimates and Forecasts 2017-2028
2.2 Global Microbial Alternative Protein Revenue Estimates and Forecasts 2017-2028
2.3 Global Microbial Alternative Protein Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Microbial Alternative Protein Sales by Region
2.4.1 Global Microbial Alternative Protein Sales by Region (2017-2022)
2.4.2 Global Sales Microbial Alternative Protein by Region (2023-2028)
2.5 Global Microbial Alternative Protein Revenue by Region
2.5.1 Global Microbial Alternative Protein Revenue by Region (2017-2022)
2.5.2 Global Microbial Alternative Protein Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Microbial Alternative Protein Sales by Manufacturers
3.1.1 Global Top Microbial Alternative Protein Manufacturers by Sales (2017-2022)
3.1.2 Global Microbial Alternative Protein Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Microbial Alternative Protein in 2021
3.2 Global Microbial Alternative Protein Revenue by Manufacturers
3.2.1 Global Microbial Alternative Protein Revenue by Manufacturers (2017-2022)
3.2.2 Global Microbial Alternative Protein Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Microbial Alternative Protein Revenue in 2021
3.3 Global Microbial Alternative Protein Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Microbial Alternative Protein Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Microbial Alternative Protein Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Microbial Alternative Protein Sales by Type
4.1.1 Global Microbial Alternative Protein Historical Sales by Type (2017-2022)
4.1.2 Global Microbial Alternative Protein Forecasted Sales by Type (2023-2028)
4.1.3 Global Microbial Alternative Protein Sales Market Share by Type (2017-2028)
4.2 Global Microbial Alternative Protein Revenue by Type
4.2.1 Global Microbial Alternative Protein Historical Revenue by Type (2017-2022)
4.2.2 Global Microbial Alternative Protein Forecasted Revenue by Type (2023-2028)
4.2.3 Global Microbial Alternative Protein Revenue Market Share by Type (2017-2028)
4.3 Global Microbial Alternative Protein Price by Type
4.3.1 Global Microbial Alternative Protein Price by Type (2017-2022)
4.3.2 Global Microbial Alternative Protein Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Microbial Alternative Protein Sales by Application
5.1.1 Global Microbial Alternative Protein Historical Sales by Application (2017-2022)
5.1.2 Global Microbial Alternative Protein Forecasted Sales by Application (2023-2028)
5.1.3 Global Microbial Alternative Protein Sales Market Share by Application (2017-2028)
5.2 Global Microbial Alternative Protein Revenue by Application
5.2.1 Global Microbial Alternative Protein Historical Revenue by Application (2017-2022)
5.2.2 Global Microbial Alternative Protein Forecasted Revenue by Application (2023-2028)
5.2.3 Global Microbial Alternative Protein Revenue Market Share by Application (2017-2028)
5.3 Global Microbial Alternative Protein Price by Application
5.3.1 Global Microbial Alternative Protein Price by Application (2017-2022)
5.3.2 Global Microbial Alternative Protein Price Forecast by Application (2023-2028)
6 North America
6.1 North America Microbial Alternative Protein Market Size by Type
6.1.1 North America Microbial Alternative Protein Sales by Type (2017-2028)
6.1.2 North America Microbial Alternative Protein Revenue by Type (2017-2028)
6.2 North America Microbial Alternative Protein Market Size by Application
6.2.1 North America Microbial Alternative Protein Sales by Application (2017-2028)
6.2.2 North America Microbial Alternative Protein Revenue by Application (2017-2028)
6.3 North America Microbial Alternative Protein Market Size by Country
6.3.1 North America Microbial Alternative Protein Sales by Country (2017-2028)
6.3.2 North America Microbial Alternative Protein Revenue by Country (2017-2028)
6.3.3 U.S.
6.3.4 Canada
7 Europe
7.1 Europe Microbial Alternative Protein Market Size by Type
7.1.1 Europe Microbial Alternative Protein Sales by Type (2017-2028)
7.1.2 Europe Microbial Alternative Protein Revenue by Type (2017-2028)
7.2 Europe Microbial Alternative Protein Market Size by Application
7.2.1 Europe Microbial Alternative Protein Sales by Application (2017-2028)
7.2.2 Europe Microbial Alternative Protein Revenue by Application (2017-2028)
7.3 Europe Microbial Alternative Protein Market Size by Country
7.3.1 Europe Microbial Alternative Protein Sales by Country (2017-2028)
7.3.2 Europe Microbial Alternative Protein Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Microbial Alternative Protein Market Size by Type
8.1.1 Asia Pacific Microbial Alternative Protein Sales by Type (2017-2028)
8.1.2 Asia Pacific Microbial Alternative Protein Revenue by Type (2017-2028)
8.2 Asia Pacific Microbial Alternative Protein Market Size by Application
8.2.1 Asia Pacific Microbial Alternative Protein Sales by Application (2017-2028)
8.2.2 Asia Pacific Microbial Alternative Protein Revenue by Application (2017-2028)
8.3 Asia Pacific Microbial Alternative Protein Market Size by Region
8.3.1 Asia Pacific Microbial Alternative Protein Sales by Region (2017-2028)
8.3.2 Asia Pacific Microbial Alternative Protein Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
8.3.12 Philippines
9 Latin America
9.1 Latin America Microbial Alternative Protein Market Size by Type
9.1.1 Latin America Microbial Alternative Protein Sales by Type (2017-2028)
9.1.2 Latin America Microbial Alternative Protein Revenue by Type (2017-2028)
9.2 Latin America Microbial Alternative Protein Market Size by Application
9.2.1 Latin America Microbial Alternative Protein Sales by Application (2017-2028)
9.2.2 Latin America Microbial Alternative Protein Revenue by Application (2017-2028)
9.3 Latin America Microbial Alternative Protein Market Size by Country
9.3.1 Latin America Microbial Alternative Protein Sales by Country (2017-2028)
9.3.2 Latin America Microbial Alternative Protein Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Microbial Alternative Protein Market Size by Type
10.1.1 Middle East and Africa Microbial Alternative Protein Sales by Type (2017-2028)
10.1.2 Middle East and Africa Microbial Alternative Protein Revenue by Type (2017-2028)
10.2 Middle East and Africa Microbial Alternative Protein Market Size by Application
10.2.1 Middle East and Africa Microbial Alternative Protein Sales by Application (2017-2028)
10.2.2 Middle East and Africa Microbial Alternative Protein Revenue by Application (2017-2028)
10.3 Middle East and Africa Microbial Alternative Protein Market Size by Country
10.3.1 Middle East and Africa Microbial Alternative Protein Sales by Country (2017-2028)
10.3.2 Middle East and Africa Microbial Alternative Protein Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 AgriProtein (South Africa)
11.1.1 AgriProtein (South Africa) Corporation Information
11.1.2 AgriProtein (South Africa) Overview
11.1.3 AgriProtein (South Africa) Microbial Alternative Protein Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 AgriProtein (South Africa) Microbial Alternative Protein Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 AgriProtein (South Africa) Recent Developments
11.2 Ynsect (France)
11.2.1 Ynsect (France) Corporation Information
11.2.2 Ynsect (France) Overview
11.2.3 Ynsect (France) Microbial Alternative Protein Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Ynsect (France) Microbial Alternative Protein Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Ynsect (France) Recent Developments
11.3 Enterra Feed Corporation (Canada)
11.3.1 Enterra Feed Corporation (Canada) Corporation Information
11.3.2 Enterra Feed Corporation (Canada) Overview
11.3.3 Enterra Feed Corporation (Canada) Microbial Alternative Protein Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Enterra Feed Corporation (Canada) Microbial Alternative Protein Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Enterra Feed Corporation (Canada) Recent Developments
11.4 Protix (The Netherlands)
11.4.1 Protix (The Netherlands) Corporation Information
11.4.2 Protix (The Netherlands) Overview
11.4.3 Protix (The Netherlands) Microbial Alternative Protein Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Protix (The Netherlands) Microbial Alternative Protein Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Protix (The Netherlands) Recent Developments
11.5 Proti-Farm Holding NV (The Netherlands)
11.5.1 Proti-Farm Holding NV (The Netherlands) Corporation Information
11.5.2 Proti-Farm Holding NV (The Netherlands) Overview
11.5.3 Proti-Farm Holding NV (The Netherlands) Microbial Alternative Protein Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 Proti-Farm Holding NV (The Netherlands) Microbial Alternative Protein Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Proti-Farm Holding NV (The Netherlands) Recent Developments
11.6 Entomo Farms (Canada)
11.6.1 Entomo Farms (Canada) Corporation Information
11.6.2 Entomo Farms (Canada) Overview
11.6.3 Entomo Farms (Canada) Microbial Alternative Protein Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 Entomo Farms (Canada) Microbial Alternative Protein Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Entomo Farms (Canada) Recent Developments
11.7 Global Bugs Asia Co., Ltd. (Thailand)
11.7.1 Global Bugs Asia Co., Ltd. (Thailand) Corporation Information
11.7.2 Global Bugs Asia Co., Ltd. (Thailand) Overview
11.7.3 Global Bugs Asia Co., Ltd. (Thailand) Microbial Alternative Protein Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 Global Bugs Asia Co., Ltd. (Thailand) Microbial Alternative Protein Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Global Bugs Asia Co., Ltd. (Thailand) Recent Developments
11.8 Aspire Food Group (U.S.)
11.8.1 Aspire Food Group (U.S.) Corporation Information
11.8.2 Aspire Food Group (U.S.) Overview
11.8.3 Aspire Food Group (U.S.) Microbial Alternative Protein Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 Aspire Food Group (U.S.) Microbial Alternative Protein Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Aspire Food Group (U.S.) Recent Developments
11.9 Tiny Farms (U.S.)
11.9.1 Tiny Farms (U.S.) Corporation Information
11.9.2 Tiny Farms (U.S.) Overview
11.9.3 Tiny Farms (U.S.) Microbial Alternative Protein Sales, Price, Revenue and Gross Margin (2017-2022)
11.9.4 Tiny Farms (U.S.) Microbial Alternative Protein Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Tiny Farms (U.S.) Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Microbial Alternative Protein Industry Chain Analysis
12.2 Microbial Alternative Protein Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Microbial Alternative Protein Production Mode & Process
12.4 Microbial Alternative Protein Sales and Marketing
12.4.1 Microbial Alternative Protein Sales Channels
12.4.2 Microbial Alternative Protein Distributors
12.5 Microbial Alternative Protein Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Microbial Alternative Protein Industry Trends
13.2 Microbial Alternative Protein Market Drivers
13.3 Microbial Alternative Protein Market Challenges
13.4 Microbial Alternative Protein Market Restraints
14 Key Findings in The Global Microbial Alternative Protein Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer